In partnership with Google and Medstro, Boston Scientific featured companies tackling healthcare with big data at its 2nd annual Connected Patient Challenge.
Big data, artificial intelligence and patient-engagement technologies were among the systems featured at yesterday’s Connected Patient Challenge hosted by Boston Scientific (NYSE:BSX) at Google’s Cambridge, Mass. facility.
The Shark Tank–style event featured 6 companies competing for a chance to work with Boston Scientific to develop their proposed products or systems.
The winning team was awarded $35,000 in services from Boston Scientific to advance their concepts, as well as $15,000 in cloud-platform credits from Google. The runner-up received $15,000 in services and $10,000 in Google credits.
The night was a culmination of a 3-month process, during which time people from all over the world submitted their ideas online to be vetted by a group of judges.
The 46 submissions were voted on by nearly 1,700 people online and eventually, the top 6 ideas were selected to attend the live event.
Last night’s program included a panel of 6 judges: Chris Coburn, the chief innovation officer at Partners Healthcare; Rob Faulkner, the managing director of Redmile Group; David Feygin, the chief digital health officer at Boston Scientific; Dr. Howard Levin, the president & chief scientific officer of Coridea; Josh Mandel, Verily’s Health IT Ecosystem lead; and Dr. Darshak Sanghavi, the chief medical officer at OptumLabs.
David Knapp, the VP of corporate research at Boston Scientific, told MassDevice that the purpose of the event is to increase the visibility of connected health advances, as well as “spur earlier stage investment”.
Each team presented their work for 7 minutes and then had a chance to answer the judges’ questions. The back-and-forth allowed the team’s a chance to defend the value of their concepts and the edge they bring to a competitive market.
“Understanding what problem or clinical need you are trying to address is fundamental to the space,” Knapp told us. “The hardest thing about this space is to figure out how you’re adding value to the system.”
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.